Compare ResMed Inc. (RMD) vs Sirius XM Holdings Inc (SIRI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ResMed Inc. vs Sirius XM Holdings Inc — how do they compare? ResMed Inc. trades at $219.5 (market cap $31.73B), while Sirius XM Holdings Inc trades at $28.71 (market cap $9.62B). The key difference: ResMed Inc. is far larger — about 3.3× Sirius XM Holdings Inc's market cap, and Sirius XM Holdings Inc pays the higher dividend (3.78%). Which is the better fit depends on your goals.
| RMD | SIRI | |
|---|---|---|
Market Cap | $31.73B | $9.62B |
Sector | Health | Media |
52-Week High | $283.28 | $32.59 |
52-Week Low | $182.82 | $19.92 |
Enterprise Value | $31.08B | $18.90B |
Dividend Yield | 1.2% | 3.78% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ResMed (RMD) trades at $221.05, down 3.2% on the day, with a bearish technical signal and key support at $218. The company reported strong Q4 2026 results, beating EPS estimates at $2.95, and maintains robust profitability with a 26.94% net income margin. Revenue growth remains solid, reaching $5.15B in 2025, though weak 2027 sales guidance has pressured the stock. A dividend of $0.66 is scheduled for payment in September 2026.
Outlook is mixed: strong fundamentals and a consensus price target of $235.70 suggest upside, but bearish technicals and investor lawsuits pose near-term risks. The stock offers value with a P/E of 21.19, yet competitive and regulatory challenges require monitoring for sustained growth.
Sirius XM Holdings (SIRI) trades at $28.80, down 0.66% today, with a bullish technical signal from moving averages and neutral oscillators. Recent earnings show mixed results, with Q1 2026 beating expectations but Q4 2025 and Q2 2026 missing. The company maintains solid profitability with a 10.23% net income margin and trades at a P/E of 11.57, below industry averages. Key developments include a YouTube partnership expected to boost EBITDA by $350–400 million by 2029, as reported by Seeking Alpha on September 8, 2026.
SIRI presents a value opportunity with undervalued metrics and analyst consensus pointing to 21% upside to the $34.86 price target. Risks include volatile earnings performance and high debt levels, though debt-to-asset ratios have improved from 94.31% in 2022 to 35.63% in 2025. Institutional interest is strong, with BlackRock and Deutsche Bank increasing stakes in Q2 2026 per SEC filings.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ResMed Inc.
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.
Read more on RMD →About Sirius XM Holdings Inc
SiriusXM Holdings is now composed of two businesses: SiriusXM and Pandora. SiriusXM transmits music, talk shows, sports, and news via its two satellite radio networks, primarily to consumers in vehicles who pay a subscription fee. The firm's radios come preinstalled on a wide range of light vehicles in the U.S. and Canada. The firm acquired Pandora Media in February 2019 via an all-stock transaction. Pandora is a streaming music platform that offers an ad-supported radio option and a paid on-demand service. Liberty Media owns 80% of SiriusXM, traded through its Liberty SiriusXM Group tracking stock.
Read more on SIRI →
